BETTINI, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 620
EU - Europa 526
AS - Asia 194
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.341
Nazione #
US - Stati Uniti d'America 618
GB - Regno Unito 291
CN - Cina 148
SE - Svezia 48
FI - Finlandia 39
IE - Irlanda 37
FR - Francia 28
DE - Germania 27
RU - Federazione Russa 24
SG - Singapore 18
IT - Italia 16
JP - Giappone 15
UA - Ucraina 13
IR - Iran 4
TR - Turchia 4
KR - Corea 3
CA - Canada 2
A2 - ???statistics.table.value.countryCode.A2??? 1
GR - Grecia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
RO - Romania 1
Totale 1.341
Città #
Southend 280
Chandler 135
Jacksonville 126
Woodbridge 61
Ann Arbor 58
Dublin 37
Ashburn 33
Houston 31
Wilmington 23
Beijing 19
Jinan 19
Shenyang 18
Lawrence 16
Princeton 16
Tokyo 15
Hebei 13
Nanjing 13
Singapore 12
Helsinki 10
Milan 8
Tianjin 8
Falls Church 7
Sindelfingen 7
Hangzhou 6
Jiaxing 5
Nanchang 5
Haikou 4
Ningbo 4
Seattle 4
Washington 4
Zhengzhou 4
Detroit 3
Fuzhou 3
Lancaster 3
Taiyuan 3
Taizhou 3
Verona 3
Boardman 2
Changsha 2
Clearwater 2
Fairfield 2
Genova 2
Kent 2
Lanzhou 2
San Mateo 2
Seoul 2
Winnipeg 2
Zanjan 2
Amsterdam 1
Auburn Hills 1
Boston 1
Bucharest 1
Changle 1
Dongguan 1
Düsseldorf 1
Grafing 1
Guangzhou 1
Los Angeles 1
Luzzara 1
Miami 1
Nashville 1
New York 1
Puxian 1
Saint Paul 1
San Diego 1
San Francisco 1
San Jose 1
Vientiane 1
Xiangfen 1
Totale 1.062
Nome #
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 102
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 98
Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients. 97
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. 97
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients 92
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 87
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 86
The determinant factors of recurrence following resection for ductal pancreatic cancer. 86
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours 83
Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours. 80
Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours. 77
Carcinoma of pancreatic body and tail: any improvement in diagnosis and treatment modalities over the past decade? 76
Diagnosi e terapia dei tumori neuroendocrini gastroenteropancreatici. 75
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 74
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 71
Risk factors for sporadic pancreatic endocrine tumours: a case-control study of prospectively evaluated patients 64
Totale 1.345
Categoria #
all - tutte 4.141
article - articoli 4.141
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020130 0 6 0 14 20 15 12 18 2 15 8 20
2020/2021169 23 24 9 37 21 14 2 13 12 1 11 2
2021/2022137 16 41 1 7 6 7 2 5 4 3 24 21
2022/2023307 17 45 16 55 35 54 3 32 38 3 5 4
2023/2024129 6 9 16 16 17 17 1 10 0 4 29 4
2024/202528 16 12 0 0 0 0 0 0 0 0 0 0
Totale 1.345